India’s Strides Buys U.S.-Compliant Plant To Make Sterile Injectables
This article was originally published in PharmAsia News
Executive Summary
Strides Arcolab, acting through its Agila Specialties unit, has committed to buy a Star Drugs and Research Labs plant already compliant with U.S. regulations, for $23.8 million.